Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Berg

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|April 22, 2018
Integrated genomic and metabolomic profiling of ISC1, an emerging Leishmania donovani population in the Indian subcontinentBart Cuypers, Maya Berg, Hideo Imamura, et al.
Frontiers in Pharmacology|July 12, 2021
The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer ModelHanne Van Spaendonk, Hannah Ceuleers, Annemieke Smet, et al.
European Journal of Immunology|June 11, 2025
Dipeptidyl Peptidase 9 in Human Leukocytes: Novel Inhibitors Induce Caspase-1- and Gasdermin-Dependent Cell DeathJoni De Loose, Kathleen Mertens, Nicolò Filippi, et al.
Gut|October 7, 2020
Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBSEluisa Perna, Javier Aguilera-Lizarraga, Morgane V Florens, et al.
Pharmaceutics|June 2, 2021
Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in RatsNikita Hanning, Michelle De Bruyn, Hannah Ceuleers, et al.
Antimicrobial Agents and Chemotherapy|March 3, 2010
Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasisMaya Berg, Linda Kohl, Pieter Van der Veken, et al.
Journal of Medicinal Chemistry|October 14, 2025
Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic PotentialPawel Brzeminski, Emile Verhulst, Adrian Fabisiak, et al.
Autophagy Reports|September 18, 2025
Biarylacetamides: a novel class of late-stage autophagy inhibitorsMélissa Lallier, Rani Robeyns, Freke Mertens, et al.
Frontiers in Chemistry|January 23, 2023
Chemically diverse activity-based probes with unexpected inhibitory mechanisms targeting trypsin-like serine proteasesAlba Ramos-Llorca, Lisse Decraecker, Valérie M Y Cacheux, et al.
European Journal of Medicinal Chemistry|December 27, 2025
In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence timeEmile Verhulst, Pawel Brzeminski, Anke de Groot, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|April 22, 2018
Integrated genomic and metabolomic profiling of ISC1, an emerging Leishmania donovani population in the Indian subcontinentBart Cuypers, Maya Berg, Hideo Imamura, et al.
Frontiers in Pharmacology|July 12, 2021
The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer ModelHanne Van Spaendonk, Hannah Ceuleers, Annemieke Smet, et al.
European Journal of Immunology|June 11, 2025
Dipeptidyl Peptidase 9 in Human Leukocytes: Novel Inhibitors Induce Caspase-1- and Gasdermin-Dependent Cell DeathJoni De Loose, Kathleen Mertens, Nicolò Filippi, et al.
Gut|October 7, 2020
Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBSEluisa Perna, Javier Aguilera-Lizarraga, Morgane V Florens, et al.
Pharmaceutics|June 2, 2021
Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in RatsNikita Hanning, Michelle De Bruyn, Hannah Ceuleers, et al.
Antimicrobial Agents and Chemotherapy|March 3, 2010
Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasisMaya Berg, Linda Kohl, Pieter Van der Veken, et al.
Journal of Medicinal Chemistry|October 14, 2025
Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic PotentialPawel Brzeminski, Emile Verhulst, Adrian Fabisiak, et al.
Autophagy Reports|September 18, 2025
Biarylacetamides: a novel class of late-stage autophagy inhibitorsMélissa Lallier, Rani Robeyns, Freke Mertens, et al.
Frontiers in Chemistry|January 23, 2023
Chemically diverse activity-based probes with unexpected inhibitory mechanisms targeting trypsin-like serine proteasesAlba Ramos-Llorca, Lisse Decraecker, Valérie M Y Cacheux, et al.
European Journal of Medicinal Chemistry|December 27, 2025
In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence timeEmile Verhulst, Pawel Brzeminski, Anke de Groot, et al.
Pageof 4